Literature DB >> 21160433

Gadolinium-enhanced liver magnetic resonance imaging using a 2-point Dixon fat-water separation technique: impact upon image quality and lesion detection.

Andrew B Rosenkrantz1, Lorenzo Mannelli, Sungheon Kim, James S Babb.   

Abstract

PURPOSE: To compare image quality and lesion detection in postcontrast liver magnetic resonance imaging (MRI) between volumetric interpolated breath-hold examination (VIBE) sequences that achieve fat suppression via chemically selective fat saturation (FS-VIBE) and a 2-point Dixon water-fat separation method (Dixon-VIBE).
MATERIALS AND METHODS: Thirty patients underwent contrast-enhanced liver MRI at 1.5 T in which Dixon-VIBE was performed immediately after a delayed FS-VIBE. Two radiologists in consensus reviewed the sequences for a variety of qualitative and quantitative image quality measures and for lesion detection.
RESULTS: Dixon-VIBE received nearly perfect scores for strength and homogeneity of fat suppression that were significantly better than scores for FS-VIBE, with an associated significant improvement in liver-fat contrast (P < 0.0001 for all comparisons). Dixon-VIBE also received significantly better scores for sharpness of intrahepatic vessels (P = 0.0029) and overall image quality (P < 0.0001). Despite a slightly longer acquisition time for Dixon-VIBE, there was no significant difference in motion artifact (P = 0.3877). There was no significant difference for sensitivity, positive predictive value, or contrast relative to background liver for focal lesions (P = 0.448, P = 0.347, and P = 0.2312, respectively).
CONCLUSIONS: For postcontrast liver MRI, Dixon-VIBE demonstrated significantly improved fat suppression. Various assessments of lesion detection showed no significant difference between sequences.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21160433     DOI: 10.1097/RCT.0b013e3181f3d57e

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  7 in total

1.  The Dixon technique and the frequency-selective fat suppression technique in three-dimensional T1 weighted MRI of the liver: a comparison of contrast-to-noise ratios of hepatocellular carcinomas-to-liver.

Authors:  Y Takatsu; T Akasaka; T Miyati
Journal:  Br J Radiol       Date:  2015-04-02       Impact factor: 3.039

2.  Usefulness of two-point Dixon fat-water separation technique in gadoxetic acid-enhanced liver magnetic resonance imaging.

Authors:  Ying Ding; Sheng-Xiang Rao; Cai-Zhong Chen; Ren-Chen Li; Meng-Su Zeng
Journal:  World J Gastroenterol       Date:  2015-04-28       Impact factor: 5.742

3.  Hepatic fat assessment using advanced Magnetic Resonance Imaging.

Authors:  Yong Pang; Baiying Yu; Xiaoliang Zhang
Journal:  Quant Imaging Med Surg       Date:  2012-09

4.  Fat saturation in dynamic breast MRI at 3 Tesla: is the Dixon technique superior to spectral fat saturation? A visual grading characteristics study.

Authors:  P Clauser; K Pinker; T H Helbich; P Kapetas; M Bernathova; P A T Baltzer
Journal:  Eur Radiol       Date:  2014-05-04       Impact factor: 5.315

Review 5.  Body MR angiography in children: how we do it.

Authors:  Rajesh Krishnamurthy; LaDonna Malone; Karen Lyons; Pamela Ketwaroo; Nicholas Dodd; Daniel Ashton
Journal:  Pediatr Radiol       Date:  2016-05-26

6.  DIfferential Subsampling with Cartesian Ordering (DISCO): a high spatio-temporal resolution Dixon imaging sequence for multiphasic contrast enhanced abdominal imaging.

Authors:  Manojkumar Saranathan; Dan W Rettmann; Brian A Hargreaves; Sharon E Clarke; Shreyas S Vasanawala
Journal:  J Magn Reson Imaging       Date:  2012-02-14       Impact factor: 4.813

7.  CAIPIRINHA-Dixon-TWIST (CDT)-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium: a solution for transient arterial-phase respiratory motion-related artifacts?

Authors:  Leonhard Gruber; Vera Rainer; Michaela Plaikner; Christian Kremser; Werner Jaschke; Benjamin Henninger
Journal:  Eur Radiol       Date:  2017-12-20       Impact factor: 5.315

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.